CASI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.69	13.47	17.08	47.11	38.7
Short-Term Investments	-	17.97	13.69	4.23	9.87
Cash & Short-Term Investments	4.69	31.44	30.77	51.34	48.57
Cash Growth	-77.49%	2.17%	-40.06%	5.69%	-
Accounts Receivable	2.61	-	9.55	12.97	9.8
Other Receivables	-	-	0.59	-	-
Total Trade Receivables	2.61	-	10.14	12.97	9.8
Inventory	2.61	5.25	15.88	6.14	1.91
Other Current Assets	2.01	2.89	2.56	2.98	1.69
Total Current Assets	11.92	39.58	59.34	73.42	61.97
Net Property, Plant & Equipment	9.95	11.36	11.63	13.23	21.82
Other Intangible Assets	0.22	0.24	1.84	1.06	12.2
Long-Term Investments	1.72	1.91	1.69	7.46	40.13
Other Long-Term Assets	0.66	0.59	0.77	1.06	2.18
Total Assets	24.46	53.67	75.27	96.23	138.3
Accounts Payable	0.56	2.72	4.44	3.29	2.22
Accrued Expenses	20.01	15.34	12.29	11.82	10.96
Unearned Revenue	-	-	-	-	2.83
Other Current Liabilities	18.86	18.39	-	1.9	-
Total Current Liabilities	39.42	36.45	16.73	17.01	13.19
Long-Term Debt	-	-	18.9	-	-
Other Long-Term Liabilities	13.63	15.37	15.48	12.3	14.33
Total Long-Term Liabilities	13.63	15.37	34.38	12.3	14.33
Total Liabilities	53.05	51.82	51.1	29.3	30.34
Common Stock	0	0	0	0	0
Treasury Stock	-9.6	-9.6	-9.6	-9.33	-8.03
Additional Paid-in Capital	718.37	713.3	695.79	691.77	696.22
Accumulated Other Comprehensive Income	-2.27	-1.77	-1.2	-0.7	1.95
Retained Earnings	-735.09	-700.08	-660.82	-637.16	-605.64
Total Common Shareholders' Equity	-28.59	1.85	24.17	44.57	84.5
Minority Interest	-	-	-	22.36	23.46
Shareholders' Equity	-28.59	1.85	24.17	66.93	107.96
Total Liabilities & Equity	24.46	53.67	75.27	96.23	138.3
Total Debt	-	0	18.9	0	0
Net Cash (Debt)	4.69	31.44	11.87	51.34	48.57
Net Cash Growth	-85.10%	164.75%	-76.87%	5.69%	-
Net Cash Per Share	-	-	0.89	3.76	3.57
Book Value	-28.59	1.85	24.17	44.57	84.5
Book Value Per Share	-	-	1.81	3.27	6.21
Tangible Book Value	-28.82	1.61	22.33	43.51	72.3
Tangible Book Value Per Share	-	-	1.67	3.19	5.31

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.